Look at ARNA - Down 10% on Friday with withdrawal from EU application, to under $7.50, today DEA gave green light to start selling Belviq for obesity in US in a month. Stock up almost $1 to $8.40...The funny thing is this was widely expected for last 4 months - why would people sell at 7.50, lol....That is why with INSM - sell if you don't believe clinical results will be favorable and buy if you believe in drug platform. Of course I believe that this will be winner. Sometimes we make better investment decisions if we actually don't pay so much attention to every trade.....=) GL to all!
Tell me about it - suffered thru so many ups and downs but stuck it through just by not following the herd but doing my own homework and talking to docs and industry veterans. Big winners were : SRPT, ACAD, AEGR, SNTS, ARNA - had some losers but luckily those were smaller positions. Just started a position here in last few weeks as think that this has potential to be best biotech spec play this year. Best to all here!